Coloplast A/s Class B · OMXCOP:COLO_B
Coloplast A/s Class B — Investor Day (2016)
11 slides from Coloplast A/s Class B's investor day presentation, 2016
Slide 1: Urology Care Update
Urology Care Update Coloplast Capital Markets Day 2016 Steffen Eichner Hovard, SVP Urology Care
Slide 2: Introducing Urology Care
Introducing Urology Care Urology Care geographical presence Urology Care at a glance • Broad and deep portfolio of implantable and single use devices for Surgical Urology procedures • Sales in 75 countries • Key regions: US, Europe, Japan, Australia, Latin America • 650 employees including productio
Slide 3: The global Urology Care market size is around DKK 11bn growing 3-5%
The global Urology Care market size is around DKK 11bn growing 3-5% Market dynamics Market size (DKKbn) Market growth • Some changes in how competitors go to market ~3 Endourology • Focus on time- and cost-effective solutions ~5% • More pervasive use of flexible scopes 5 • Increased competitor conce
Slide 4: The industry has been consolidating and future consolidation is likely
The industry has been consolidating and future consolidation is likely Competitors Men’s Health Female Pelvic Health Endourology General Urology Regional/National competitors Page 4
Slide 5: The biggest industry change is occurring in the Female Pelvic Health business
The biggest industry change is occurring in the Female Pelvic Health business • Consolidation for both physicians and industry continues to occur Industry & • In January, FDA issued two final orders to strengthen data regulatory requirements for surgical mesh to repair pelvic organ prolapse changes
Slide 6: Coloplast enjoys a 10-15% global market share, and is positioned to expand further
Coloplast enjoys a 10-15% global market share, and is positioned to expand further Regional Coloplast market share In percent Europe United States Rest of World ~25% ~25% ~15% ~15% 5% - 10% - 5% - ~15% ~15% 10% 15% 10% ~5% ~0% ~1% Men’s Men’s Men’s urology Health General Urology FemaleFemale urology
Slide 7: In 2012 we embarked on a journey towards becoming a global leader within Urology Care
In 2012 we embarked on a journey towards becoming a global leader within Urology Care Years 2018- • Increasing market share • Global Standard For Listening Years 2016-18 And Responding • Globalised • Operating-As-One • Aligned Execution • Leveraging Effect Years 2013-15 • Globalising • Maximizing Pr
Slide 8: Innovation is key to becoming a global leader
Innovation is key to becoming a global leader Titan® inflatable penile implant Altis ® single incision sling Isiris ® cystoscope Page 8
Slide 9: We are becoming an industry leader by executing on the following strategies
We are becoming an industry leader by executing on the following strategies Geographical Operating As Commercial Expansion One Innovation Execution Expanding our Providing a consistent Setting the global Delivering commercial geographical coverage by product portfolio and standard for listening exce
Slide 10: Urology Care will continue to deliver high growth and strong profitability
Urology Care will continue to deliver high growth and strong profitability Net revenue (DKKm) EBIT (%) 4,000 Strong 30% Profitability 3,500 25% 3,000 Healthy 20% 2,500 Profitability 2,000 2,000 1,400 15% 1,500 1,200 10% 1,000 5% 500 - 0% 2012/2013 2012/2013 2014/2015 2014/15 Future Future Page 10
Slide 11: Our mission, values and vision
Our mission Making life easier for peoplé with intimate healthcare needs Our values Closeness... to better understand. - Passion... to make a difference Respect and responsibility... to 0 guide | US: Our vision Setting the global standard for listening and responding: Coloplast A/S - Ostomy Care / C